ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
Condition(s):Malignant MesotheliomaLast Updated:November 6, 2013Unknown status
Hide Studies Not Open or Pending
Condition(s):Malignant MesotheliomaLast Updated:November 6, 2013Unknown status
Condition(s):Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Lupus Erythematosus, SystemicLast Updated:November 12, 2019Terminated
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:May 8, 2023Recruiting
Condition(s):Adenoma Detection Rate; ColonoscopyLast Updated:February 15, 2023Recruiting
Condition(s):POEMS SyndromeLast Updated:November 13, 2023Completed
Condition(s):PsoriasisLast Updated:February 28, 2024Recruiting
Condition(s):Multiple MyelomaLast Updated:June 18, 2021Terminated
Condition(s):Hepatocellular CarcinomaLast Updated:April 25, 2018Completed
Condition(s):Pancreas AdenocarcinomaLast Updated:November 1, 2019Unknown status
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:May 9, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.